<DOC>
	<DOC>NCT01870466</DOC>
	<brief_summary>The purpose of this study is to evaluate pharmacodynamic drug interaction between cilostazol and statins (simvastatin as a CYP3A substrate and rosuvastatin as a non-CYP3A substrate) in healthy male subjects.</brief_summary>
	<brief_title>Pharmacodynamic Drug Interaction Between Cilostazol and Statins</brief_title>
	<detailed_description>Subjects suitable for this study will visit to the Clinical Trial Center, Samsung Medical Center for 7 days and pharmacodynamic samplings will be performed following the administration of study drugs.</detailed_description>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male subjects aged 20 55 years A body mass index in the range 18.5 27 kg/m2 Willingness to participate during the entire study period Written informed consent after being fully informed about the study procedures Any past medical history of hepatic, renal, neurologic, cardiovascular, respiratory, endocrine, hematooncologic or psychiatric disease Active bleeding or bleeding tendency History of gastrointestinal disease or surgery possibly affecting drug absorption History of clinically significant drug hypersensitivity Use of medication within 7 days before the first dose Heavy drinker (&gt;140 g/week) Whole blood donation during 60 days before the study Judged not eligible for study participation by investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>